Accumetrics
Accumetrics is at the forefront of revolutionizing the way doctors manage the tens of millions of patients who take antiplatelet drugs to prevent heart attack, stroke and other potentially life-threatening cardiovascular events. Individualised Antiplatelet Therapy – Is There a Role for Platelet Function Testing in Routine Clinical Practice?
Accumetrics is a privately-held company based in San Diego, California. The company develops, manufactures, and markets the VerifyNow® System, a comprehensive suite of tests for the assessment of platelet response to antiplatelet therapies. The tests are fully automated and easy-to-use allowing physicians an accurate way to assess platelet response to optimize the effectiveness of antiplatelet therapies, and to guide treatment decisions in patients who may be at risk of a life threatening thrombosis event or bleeding complication.
Accumetrics aim provide patients and healthcare professionals the highest quality clinical evidence that will allow for improved management of cardiovascular disease. Through offering products and services that are of the highest quality, we will continually strive to exceed the expectations of our customers, our shareholders and our employees.
Jochem Wouter van Werkum, Jean-Philippe Collet
European Cardiology, 2010;6(1):41-49
Featured Company Products
VerifyNow® P2Y12 Test
Thienopyridines such as Plavix® (clopidogrel) and Effient® (prasugrel) block the P2Y12 ADP binding site on the platelet. The VerifyNow P2Y12 Test uses an ADP agonist to induce...
|
VerifyNow Aspirin Assay
Aspirin binds to the COX-1 enzyme to prevent the conversion of arachidonic acid to thromboxane A22, which result in platelet activation. The VerifyNow® Aspirin Assay...
|
